MAAB Group is an investment and trading company specialized in incubating and commercializing innovative medical technologies. The company is headquartered in New Zealand with operations in China, UK and Denmark through our trusted partners. MAAB Probiotics® is MAAB’s portfolio for evidence-based probiotic products produced in Denmark with GMP standards. MAAB Group invests in probiotic innovation and is committed to promoting science-backed health products in a global world with local partners.